Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yoori Lee currently holds 15,000 shares of AIT Therapeutics, Inc. (AITB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yoori Lee has been a net buyer of AITB stock. They have purchased $44.8K and sold $0 worth of shares.
Yoori Lee's most recent insider trade was on Nov 22, 2024, when they sold 25,000 shares at $0.00 per share.
Yoori Lee serves as Executive at AIT Therapeutics, Inc. (AITB). They have executed 20 insider transactions totaling $44.8K over their tenure at the company.
Yoori Lee holds the position of Executive at AIT Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Yoori Lee has shown a buying trading pattern, with $44.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Yoori Lee was on Jun 3, 2019, when they purchased $25.0K worth of XAIR shares. This transaction involved 4,855 shares at $5.15 per share.
Yoori Lee currently owns 15,000 shares of AIT Therapeutics, Inc. (AITB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yoori Lee's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yoori Lee has 20 Form 4 filings on record as an insider at AIT Therapeutics, Inc..
Set alerts for Yoori Lee and 40,000+ other insiders.